2 September 2010

Sanderson

HOLD

16/10/2008 James Crux

Growing software and IT services specialist Sanderson has warned that annual sales and profits to September will disappoint following recent slowdown in the retail sector.

In a mixed trading missive, Sanderson – now focused on the high-growth ‘multi-channel’ (online trading and mail order) segment of retail as well as the manufacturing sector – said revenues would weigh in at around £27.5m, producing creditable adjusted pre-tax profits ‘of not less than £3m’. When confirmed next month, sales will still represent 52% growth year on year, although both turnover and profit will be below analysts’ estimates of £30m and £3.9m respectively and 2009 forecasts have been downgraded.

Performance within the manufacturing and multi-channel sales businesses met expectations last year, but there was a shortfall from the group’s retail operations, ‘mainly at the smaller end of the market’, where several clients delayed or withdrew projects and software licence purchases. This trend was marked towards the tail end of the year, traditionally a highly profitable period.

Despite this blip, the overall picture at Sanderson is anything but doom and gloom. Cash flows remain strong – the annual operating profit to cash conversion rate was 100% – and net bank debt is now less than £11m.

Moreover, Sanderson’s business model remains robust, based on a high proportion of recurring revenues from a broad and established client base. Its shares, recommended by Growth Company Investor at 52.5p in 2007, have had a disappointing ride, though we still like Sanderson’s solid income and growth credentials long term. Based on an expected 2.7p dividend, the yield on offer is nearly 12%. Sit tight.

Growth Company Investor subscribers have full access to all our AIM and small-cap share recommendations. To subscribe today with a half-price offer, and gain immediate access to all the recommendations, click here.

Sector: Software & Computer Services

Companies: Sanderson

Market cap: £9.98m

PE Forecast: n/a

Share price: 23p

Subscribe today


More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.

Subscribe today and save 50%

VCT Report 2010

VCT Report 2010 uncovers the money available

for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted

company.

Order VCT Report 2010 today using this online form

Cash Shells Directory 2010

A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.

Coverage of AIM, techMARK and PLUS Markets

Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.

Take control of your investments

A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.

The Financial Times Guide to Personal Tax

is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.

The AIM Guide Spring 2010

The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).

A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!

Share recommendations and small-cap stock picks

Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.

Popular Recommendations

Latest Recommendations

Delcam 01/09/2010

Delcam, the international seller of CAD/CAM software to the engineering, aerospace and healthcare sectors among others, is a cash-generative small-cap seeing recovery in its markets.

Antisoma 01/09/2010

Bombed-out biotech play Antisoma is hoping two of its drugs will lead to good fortune after experiencing disaster with lung cancer treatment ASA404.

GW Pharmaceuticals 31/08/2010

GW Pharmaceuticals has won approval from Health Canada for its cannabis-based Sativex product to treat spasticity caused by Multiple Sclerosis.

More Recommendations

Sectors

Vitesse Media Events